<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>55</patient-age><report-id>PHHY2011CA64715</report-id><gender>male</gender><reactions><reaction>Knee infection post surgery</reaction><reaction>Left lower knee deep vein thrombosis following his surgery</reaction><reaction>Swelling at knee</reaction><reaction>Low HB</reaction><reaction>Having diarrhea and had about 2-3 bowel movements/day</reaction><reaction>WBC low at 3.6</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>GILENYA</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Relapsing-remitting multiple sclerosis</indication></indications><outcomes/><country>Canada</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149674_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152621</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>3</safetyreportversion>
		<safetyreportid>PHHY2011CA64715</safetyreportid>
		<primarysourcecountry>CA</primarysourcecountry>
		<occurcountry>CA</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2011-07-14</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-17</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2011CA64715</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Yves</reportergivename>
			<reporterfamilyname>Lappierre</reporterfamilyname>
			<reportercountry>CA</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>CA</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>CA</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reportergivename>Vanessa</reportergivename>
			<reporterfamilyname>Spyropoulos</reporterfamilyname>
			<reportercountry>CA</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>JT</patientinitial>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19560725</patientbirthdate>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Knee arthroplasty</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120426</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
				<patientmedicalcomment>Another knee surgery at the end og Aug 2012 as he had developed a knee infection post the first surg</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hip arthroplasty</patientepisodename>
				<patientmedicalcomment>Planning for surgery.</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Knee infection post surgery</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Joint infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Arthritis infective</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Left lower knee deep vein thrombosis following his surgery</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Deep vein thrombosis postoperative</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Deep vein thrombosis postoperative</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Swelling at knee</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Swelling of knees</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Joint swelling</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Low HB</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Hemoglobin low</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Haemoglobin decreased</reactionmeddrapt>
				<reactionfirsttime>305</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Having diarrhea and had about 2-3 bowel movements/day</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Diarrhea</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Diarrhoea</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20110713</reactionstartdate>
				<reactionfirsttime>2</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>2</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>WBC low at 3.6</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>WBC decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>White blood cell count decreased</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120105</reactionstartdate>
				<reactionfirsttime>178</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>178</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120511</testdate>
				<testname>Haemoglobin</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>White blood cell count</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120105</testdate>
				<testname>White blood cell count</testname>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>GILENYA</medicinalproduct>
				<obtaindrugcountry>CA</obtaindrugcountry>
				<drugauthorizationnumb>22-527</drugauthorizationnumb>
				<drugauthorizationcountry>CA</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>0.5 mg, daily</drugdosagetext>
				<drugdosageform normalized="capsule">Capsule</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Relapsing-remitting multiple sclerosis</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-07-12</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-03-12</drugenddate>
				<drugtreatmentduration>245</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FINGOLIMOD</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Arthritis infective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Arthritis infective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis postoperative</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis postoperative</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Joint swelling</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Joint swelling</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>GILENYA</medicinalproduct>
				<obtaindrugcountry>CA</obtaindrugcountry>
				<drugauthorizationnumb>22-527</drugauthorizationnumb>
				<drugauthorizationcountry>CA</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>0.5 mg, daily</drugdosagetext>
				<drugdosageform normalized="capsule">Capsule</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FINGOLIMOD</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Arthritis infective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Arthritis infective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis postoperative</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis postoperative</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Joint swelling</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Joint swelling</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2011CA64715, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>spontaneous report received from a consumer (patient) via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 14 Jul 2011 and follow up report from consumer (patient) received via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 05 Jan 2012 and follow up report received from <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 07 Mar 2012 and combined follow up report received from consumer (patient) via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 07 May 2012 and from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 11 May 2012 and follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 20 Jun 2012 and combined follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 17 Jan 2013 and consumer (patient) via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 18 Jan 2013: This report refers to a 54-year old male patient. This patient started <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>with <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>(<Semaphore x="576789" class="Medicine" value="fingolimod" score="0.49" ID="186392">fingolimod</Semaphore>) at a daily dose of 0.5 mg for <Semaphore x="3115890" class="MedDRA LLT" value="Multiple sclerosis relapse" score="1.00" ID="10048393"><Semaphore x="2451967" class="Disease or Finding" value="Recurrent Disease, Distant Site" score="1.00" ID="C55073">relapsing </Semaphore>remitting <Semaphore x="2245768" class="Disease or Finding" value="Multiple Sclerosis" score="1.00" ID="C3243">multiple sclerosis </Semaphore></Semaphore>(RRMS) from 12 Jul 2011. On 13 Jul 2011, this patient started <Semaphore x="1936750" class="Procedure" value="Findings-Based Question" score="0.58" ID="C91103">having <Semaphore x="2906722" class="MedDRA LLT" value="Diarrhoea" score="1.00" ID="10012735">diarrhea </Semaphore>and had </Semaphore>about 2-3 <Semaphore x="1839006" class="Disease or Finding" value="Defecation Urgency" score="1.00" ID="C62788">bowel movements </Semaphore>per day. On 05 Jan 2012, this patient reported that he was informed by his <Semaphore x="2350521" class="Disease or Finding" value="Orthostatic Hypotension" score="1.00" ID="C84970">orthopedic </Semaphore>that his <Semaphore x="2110489" class="Disease or Finding" value="Leukopenia" score="1.00" ID="C26816"><Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">white <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">blood cell </Semaphore></Semaphore>
       <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
        <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
         </Semaphore></Semaphore></Semaphore>
      <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
       <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
        <Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939">count </Semaphore></Semaphore></Semaphore>
      <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
       <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">
        </Semaphore>
       </Semaphore>
      <Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939">(<Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">WBC</Semaphore></Semaphore>
      <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">) decreased </Semaphore></Semaphore>to 3.6 as per the recent <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">blood test</Semaphore>. Baseline <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">WBC </Semaphore>of the patient was 7.0. The patient stated that he was waiting for a <Semaphore x="3006351" class="MedDRA LLT" value="Hip arthroplasty" score="1.00" ID="10020096"><Semaphore x="2026507" class="AnatomicStructure" value="Hip" score="1.00" ID="C64193">hip </Semaphore>replacement </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>on his left side. The date of <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>was unknown, but he was informed to stop <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>at least 4-6 weeks <Semaphore x="2424297" class="Procedure" value="Prior Surgery" score="1.00" ID="C16169">prior to <Semaphore x="3266576" class="MedDRA LLT" value="Surgery" score="1.00" ID="10042609">surgery </Semaphore></Semaphore>since his <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942"><Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">white <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">blood cell </Semaphore></Semaphore>
      <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
       <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
        </Semaphore></Semaphore></Semaphore>
     <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
      <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
       <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">count </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
      </Semaphore>was low</Semaphore>. He underwent a pre planned <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>replacement on 26 Apr 2012. He was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2896219" class="MedDRA LLT" value="Deep vein thrombosis" score="1.00" ID="10051055">left lower <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein thrombosis </Semaphore></Semaphore>(<Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DVT</Semaphore>) following his <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery</Semaphore>. He was on <Semaphore x="1366732" class="Medicine - Xarelto - Frequency" value="twice" score="0.49" ID=""><Semaphore x="1366718" class="Medicine - Xarelto - Dose" value="15mg" score="0.49" ID=""><Semaphore x="1366747" class="Medicine" value="Xarelto" score="0.74" ID="195809">Xarelto </Semaphore>(<Semaphore x="1142741" class="Medicine - rivaroxaban - Dose" value="15mg" score="0.49" ID=""><Semaphore x="1142770" class="Medicine" value="rivaroxaban" score="0.74" ID="195805">rivaroxaban</Semaphore>) <Semaphore x="4908035222798337" class="Medicine - rivaroxaban - Dose" value="10 mg" score="0.49" ID="">10 mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="4908095352340481" class="Medicine - rivaroxaban - Frequency" value="for" score="0.49" ID="">for </Semaphore></Semaphore>3 months or less. On 11 May 2012, his <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">hemoglobin </Semaphore>was reported as 90 (units unspecified). The <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>planned to wait <Semaphore x="1405075" class="Disease or Finding" value="Aagenaes Syndrome" score="1.00" ID="C35709">a little </Semaphore>while before restarting the patient on <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya</Semaphore>. The plan was to wait until the patient's <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">hemoglobin </Semaphore>and mobility had increased. It was reported that his <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">neurologist </Semaphore>would be notified about the events. It was reported that he <Semaphore x="1936750" class="Procedure" value="Findings-Based Question" score="0.58" ID="C91103">had <Semaphore x="3267402" class="MedDRA LLT" value="Swelling" score="1.00" ID="10042674">swelling </Semaphore></Semaphore>at the <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>and it was improving. The patient saw the <Semaphore x="2350521" class="Disease or Finding" value="Orthostatic Hypotension" score="1.00" ID="C84970">orthopedic </Semaphore><Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">surgeon </Semaphore>on 14 Jun 2012, who had tried to do a puncture to remove fluid from his <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee</Semaphore>, but he was unable to <Semaphore x="2588752" class="Procedure" value="Study of High Risk Factors" score="1.00" ID="C62697">withdraw </Semaphore>any liquid. Therefore, the <Semaphore x="2597501" class="Disease or Finding" value="Swelling" score="1.00" ID="C3399">swelling </Semaphore>was thought to be related to <Semaphore x="2055572" class="Disease or Finding" value="Inflammation" score="1.00" ID="C3137">inflammation</Semaphore>. He was prescribed Apo <Semaphore x="905625" class="Medicine" value="Naproxen" score="0.74" ID="281524">Naproxen </Semaphore>twice daily (<Semaphore x="905625" class="Medicine" value="Naproxen" score="0.74" ID="281524">naproxen</Semaphore>) and <Semaphore x="574637" class="Medicine" value="ferrous sulfate" score="0.49" ID="251122">ferrous sulfate </Semaphore><Semaphore x="2467295502794753" class="Medicine - ferrous sulfate - Dose" value="300mg" score="0.49" ID="">300mg </Semaphore><Semaphore x="2467673459916801" class="Medicine - ferrous sulfate - Frequency" value="twice" score="0.49" ID="">twice </Semaphore>daily. The patient had to continue <Semaphore x="1366732" class="Medicine - Xarelto - Frequency" value="twice" score="0.49" ID=""><Semaphore x="1366718" class="Medicine - Xarelto - Dose" value="15mg" score="0.49" ID=""><Semaphore x="1366747" class="Medicine" value="Xarelto" score="0.74" ID="195809">Xarelto </Semaphore>(<Semaphore x="1142741" class="Medicine - rivaroxaban - Dose" value="15mg" score="0.49" ID=""><Semaphore x="1142770" class="Medicine" value="rivaroxaban" score="0.74" ID="195805">rivaroxaban</Semaphore>) <Semaphore x="4908035222798338" class="Medicine - rivaroxaban - Dose" value="15mg" score="0.49" ID="">15mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="4908095352340482" class="Medicine - rivaroxaban - Frequency" value="twice" score="0.49" ID="">twice </Semaphore></Semaphore>daily. He also wore compression stockings and had <Semaphore x="2398392" class="Procedure" value="Physical Therapy" score="1.00" ID="C15302">physiotherapy </Semaphore>three times a week. The patient would be going for <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>work next month. On an unspecified date in the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of Aug 2012, the patient underwent a second <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>as he had developed a <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>post the <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery</Semaphore>. He was treated with intravenous (IV) antibiotics for 6 weeks and with <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>antibiotics for 5 weeks. The patient received last dose of <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>on 12 Mar 2012. <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">Treatment </Semaphore>with <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>was restarted on an unspecified date. The patient had his last follow up with the orthopedist on 03 Jan 2013. The <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>reported the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the events <Semaphore x="2896202" class="MedDRA LLT" value="Deep vein thrombosis postoperative" score="1.00" ID="10066881"><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein <Semaphore x="3198661" class="MedDRA LLT" value="Postoperative thrombosis" score="1.00" ID="10050902">thrombosis </Semaphore></Semaphore>
     <Semaphore x="3198661" class="MedDRA LLT" value="Postoperative thrombosis" score="1.00" ID="10050902">postoperative </Semaphore></Semaphore>and <Semaphore x="3054701" class="MedDRA LLT" value="Joint swelling" score="1.00" ID="10023232"><Semaphore x="2597501" class="Disease or Finding" value="Swelling" score="1.00" ID="C3399">swelling </Semaphore>of the <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knees </Semaphore></Semaphore>as condition improving and not reported for other events. The <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>assessed the event <Semaphore x="2896202" class="MedDRA LLT" value="Deep vein thrombosis postoperative" score="1.00" ID="10066881"><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep vein <Semaphore x="3198661" class="MedDRA LLT" value="Postoperative thrombosis" score="1.00" ID="10050902">thrombosis </Semaphore></Semaphore>
     <Semaphore x="3198661" class="MedDRA LLT" value="Postoperative thrombosis" score="1.00" ID="10050902">postoperative </Semaphore></Semaphore>as medically significant and not suspected to be related to <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya</Semaphore>.Consumer (patient) follow up received via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 05 Jan 2012: A new event with <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data was updated.Follow up report received from <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>on 07 Mar 2012: Patient's <Semaphore x="3006351" class="MedDRA LLT" value="Hip arthroplasty" score="1.00" ID="10020096"><Semaphore x="2026507" class="AnatomicStructure" value="Hip" score="1.00" ID="C64193">hip </Semaphore>and <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>replacement </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>plan date was updated.Combined follow up report received via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program from the consumer (patient) on 07 May 2012 and from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 11 May 2012: Date of <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery</Semaphore>, <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data, a new event (lower <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DVT</Semaphore>) and its <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>was updated.Follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 20 Jun 2012: New event <Semaphore x="3054701" class="MedDRA LLT" value="Joint swelling" score="1.00" ID="10023232">of <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="2597501" class="Disease or Finding" value="Swelling" score="1.00" ID="C3399">swelling</Semaphore></Semaphore>, its <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>and the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome</Semaphore>, date of <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>replacement and last dose of <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>were updated.Combined follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician </Semaphore>on 17 Jan 2013 and consumer (patient) via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>Go program on 18 Jan 2013: Information related to <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">procedure </Semaphore>(second <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>in Aug 2012), new event (<Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection</Semaphore>), <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore><Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>(antibiotics), action taken with <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>(restarted, reported by the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.68" ID="C19254">physician</Semaphore>) and medical narrative (last orthopedist follow up on 03 Jan 2013) was updated.</narrativeincludeclinical>
				<sendercomment>Medic comment: The case is confounded by the history of surgical procedure. The event knee infection is conservatively assessed as suspected. The event DVT has been assessed as not-suspected in agreement with HCP reported causality and will be reassessed after the availability of follow up.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>